Thyrogen recombinant thyroid stimulating hormone data

GENZ announced that results of a second Phase III trial of Thyrogen showed that radioiodine scans in patients using Thyrogen were equivalent to those from patients stopping therapy with thyroid hormone, without symptoms of hypothyroidism.

Withdrawal from replacement thyroid hormone

Read the full 403 word article

How to gain access

Continue reading with a
two-week free trial.